Ezetimibe and Sleep: What the Fatigue Data Can Tell You

If your sleep changes after starting ezetimibe, the practical question is whether the medicine deserves closer review. The fatigue figures can inform that conversation, but they cannot answer it on their own. Feeling low on energy and having trouble falling or staying asleep are different experiences. Treating them as interchangeable makes the evidence look more conclusive than it is.

What the pooled fatigue figures measure

The ZETIA prescribing information reports these separate trial databases.[1] The trial dose was 10 mg/day; this describes the research, not an individual dosing recommendation.

These are pooled label tables, not IMPROVE-IT-specific rates. The label cautions against direct comparisons across different drugs’ trials and notes that trial rates may differ from clinical practice.[1]

The denominators matter. The first comparison concerns people receiving ezetimibe alone versus placebo. The second concerns adding ezetimibe to statin treatment versus statin treatment alone. Combining those populations into one “sleep side-effect rate” would erase both the treatment context and the outcome actually recorded.

The observed fatigue differences are 0.9 and 0.4 percentage points, respectively. Neither difference estimates how many people developed insomnia, nightmares, or daytime sleepiness. Nor does a median treatment duration tell you when a symptom began or how long it lasted.

Separate your symptom from the trial endpoint

Start with what changed. “I feel tired” may mean reduced stamina, a heavy feeling after ordinary tasks, an urge to nap, or exhaustion after lying awake. Those descriptions lead to different questions. Someone who sleeps their usual hours but lacks energy needs a different assessment from someone who spends hours awake despite wanting to sleep.

A useful note for your appointment is specific rather than exhaustive. Describe difficulty falling asleep, repeated waking, or early waking separately from daytime tiredness. Include when each began, how often it happens, its severity, and whether it affects driving, work, concentration, or ordinary activities.

Add the timing of all new medicines and dose changes—not just ezetimibe—along with supplements and relevant changes in routine. Record whether fatigue preceded disrupted sleep or followed it. This gives your clinician a sequence to interpret; it does not automatically identify a culprit. Timing is a clue, not a diagnosis.

Turn the uncertainty into a practical plan

You do not need to wait six weeks before raising a troublesome change. Seek earlier review when symptoms substantially impair daily function; avoid driving if you cannot stay alert. Ask what other explanations warrant assessment and what follow-up would help distinguish them.

A medication review can address whether a supervised regimen change is reasonable and what outcome would count as meaningful improvement. Agreeing on that outcome beforehand—such as fewer prolonged awakenings rather than simply “feeling better”—makes follow-up more useful. No particular adjustment is guaranteed to resolve the problem.

Persistent insomnia also deserves attention in its own right. An American Academy of Sleep Medicine guideline strongly recommends multicomponent cognitive behavioral therapy for insomnia for adults with chronic insomnia. It conditionally recommends against sleep hygiene as the sole treatment.[2] This is general insomnia guidance, not evidence that a particular treatment fixes ezetimibe-related symptoms. The aim is to investigate the medication question without leaving the sleep problem untreated.

Frequently asked questions

›How does Zetia affect daily life?

Effects vary. If you notice reduced energy, track what you can comfortably do, whether concentration changes, and whether sleepiness affects safety. Distinguishing fatigue from disrupted sleep gives your clinician more useful information than a general report of feeling unwell.

›Does ezetimibe cause insomnia?

Insomnia is not listed in the checked ZETIA adverse-reaction text.[1] That absence cannot establish zero risk or explain a person’s symptoms. Describe new difficulty falling or staying asleep, its timing and other medication changes during the review.

›Should I take Zetia in the morning or at night?

The label allows once-daily use with or without food.[1] These sources do not prove a sleep advantage from switching times. A pharmacist or prescriber can reconcile your actual regimen, including other medicines, before you change it.

›Can Zetia cause vivid dreams or nightmares?

The pooled fatigue tables did not measure vivid dreams or nightmares. Record when the dreams began, whether they interrupt sleep and any concurrent medication or supplement changes; that is a different question from a fatigue percentage.

›Does lowering cholesterol affect sleep quality?

A cholesterol measurement does not measure sleep quality. Report sleep changes separately rather than treating a lower LDL result as an explanation for either better or worse sleep.

›Is fatigue a common side effect of ezetimibe?

Fatigue was reported by a small minority in the pooled trials, slightly more often in the ezetimibe groups than their comparators.[1] The table gives the exact rates. Those population findings cannot predict whether a particular person's fatigue is medication-related.

›Can I take melatonin while on Zetia?

Ask a pharmacist or prescriber to review the supplement’s actual ingredients and strength, your other medicines and the sleep problem you want to address. The fatigue tables and adult insomnia guideline do not establish a melatonin dose or its suitability alongside your regimen.

›How long do Zetia side effects last?

The label’s median trial durations describe time on study treatment, not how long an adverse effect lasts. Report persistent, worsening or disruptive symptoms without waiting for a fixed four-to-six-week window.

›Does Zetia cause daytime drowsiness?

The reported fatigue endpoint does not establish daytime drowsiness. An urge to fall asleep differs from low energy, although both can occur together. Describe that distinction during review, and avoid driving when you cannot stay alert.

›Will stopping Zetia improve my sleep?

A sleep change needs review before changing cholesterol treatment. Discuss the timing, other possible contributors and whether a supervised change is appropriate. Agree on the sleep outcome and follow-up to assess; improvement after stopping cannot be promised.

References

Sources checked October 14, 2026.

1. Organon. ZETIA (ezetimibe) prescribing information. DailyMed. Revised February 2024; updated November 25, 2025. Sections 2 and 6.1. Prescribing information.
2. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. 2021. PMID: 33164742. PubMed abstract.